Literature DB >> 20707891

Redo-redo aortic root replacement with a mechanical valved conduit in a patient with von Willebrand's disease: Case report.

Kasra Shaikhrezai1, Usman Bashir, Sheena Millar, Julia Anderson, Edward T Brackenbury.   

Abstract

A 40 year-old female, with a history of cardiac surgery for congenital aortic valve stenosis and von Willebrand's disease (VWD) presented with increasing shortness of breath due to mixed aortic valve dysfunction. With a paucity of such cases in the literature, we describe the successful outcome of a patient with VWD who underwent elective redo-redo aortic root replacement with a mechanical valved conduit. She was given a three-month trial of warfarin pre-operatively to evaluate the extent of bleeding risk. Her post-operative course was uneventful and she was discharged home after six days.

Entities:  

Mesh:

Year:  2010        PMID: 20707891      PMCID: PMC2933600          DOI: 10.1186/1749-8090-5-59

Source DB:  PubMed          Journal:  J Cardiothorac Surg        ISSN: 1749-8090            Impact factor:   1.637


  4 in total

1.  Peri-operative management of an adult patient with type 2N von Willebrand's disease scheduled for coronary artery bypass graft.

Authors:  V Gerling; J R Lahpor; W Buhre
Journal:  Anaesthesia       Date:  2007-04       Impact factor: 6.955

2.  Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis.

Authors:  F I Pareti; A Lattuada; C Bressi; M Zanobini; A Sala; A Steffan; Z M Ruggeri
Journal:  Circulation       Date:  2000-09-12       Impact factor: 29.690

Review 3.  Perioperative management of patients with von Willebrand's disease.

Authors:  C B Cameron; N Kobrinsky
Journal:  Can J Anaesth       Date:  1990-04       Impact factor: 5.063

4.  Acquired von Willebrand disease type IIA in patients with aortic valve stenosis.

Authors:  Kazunori Yoshida; Satoshi Tobe; Masahito Kawata
Journal:  Ann Thorac Surg       Date:  2006-03       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.